Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

A2. PK/PD studies

Poster Session: PK/PD Studies

(P-1258) Unlocking Potentials: The Impact of Meropenem, Meropenem-vaborbactam, and Ceftazidime-avibactam in Combatting Carbapenem-Resistant Enterobacter cloacae in Epithelial Lining Fluid and Serum

Friday, October 18, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Presenting Author(s)

  • TL

    Thomas Lavoie, PharmD

    Infectious Diseases Clinical Research Fellow
    Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI; College of Pharmacy, University of Rhode Island, Kingston, RI
    mattapoisett, Massachusetts, United States

    • Co-Author(s)

  • KD

    Kathryn E. Daffinee, BS

    Laboratory Manager
    Providence VA Medical Center
    Providence, Rhode Island, United States

  • jason M. Pogue, PharmD

    Clinical Professor
    University of Michigan, College of Pharmacy
    Ann Arbor, MI, United States

  • BA

    Brahim Achour, MPharm, PhD

    College of Pharmacy, University of Rhode Island, Kingston, RI
    Kingston, Rhode Island, United States

  • Kerry L. LaPlante, Pharm.D., FCCP, FIDSA, FIDP

    Professor and Chair
    1. Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States 2. Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States 3. College of Pharmacy, University of Rhode Island, Kingston, RI, United States 5. Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI
    Kingston, Rhode Island, United States